Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib.

J Hepatocell Carcinoma · 2021 · PMC8643200 · PMID 34877268

Europe PMC DOI

hedged sentence

0.0790

closest p · 1.6× alpha

0.0790

boldest claim

The sentences

a clear trendp=0.079so close (0.05 < p ≤ 0.1)

There was a clear trend towards shorter OS (4.7 (95% CI: 3.2–6.1) vs 11.3 (95% CI: 9.1–13.4) months, p=0.079) in patients with ABT vs without ABT ( Supplemental Figure 1 ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.